UBS Faces Dual Pressure as SNB Dismisses Capital Rule Complaints

The battle over Switzerland’s new capital requirements for UBS is escalating on multiple fronts, with the country’s central bank pushing back against the lender’s warnings while the government’s proposals land somewhere between compromise and confrontation. The Swiss National Bank has made clear it sees no reason to soften its stance, even as UBS warns of competitive damage and investors grow increasingly jittery.

SNB President Martin Schlegel took the unusual step of publicly defending the planned “too-big-to-fail” reforms in an interview with the Neue Zürcher Zeitung, describing the measures as targeted and proportionate. His remarks directly countered warnings from UBS Chairman Colm Kelleher, who had flagged the risk of unavoidable strategic decisions if the rules go through as drafted. In banking circles, speculation has surfaced about a potential headquarters relocation to New York, unsettling major foreign shareholders such as BlackRock and Vanguard. Roughly 80% of UBS shares are held outside Switzerland.

The government’s proposal, approved by the Federal Council, calls for full equity backing of foreign subsidiaries — a significant shift from the current practice that allows heavy reliance on debt financing. The regulator estimates the additional capital required for the Swiss entity at around $20 billion, though UBS puts the figure closer to $22 billion and has described the official calculations as misleading. The final impact, if enacted without changes, would wipe out roughly $4 billion of common equity tier 1 capital at the group level and shave nearly one percentage point off the CET1 ratio.

Market Sentiment Sours as Political Battle Looms

The uncertainty is taking a toll on the stock. UBS shares were trading at €35.20 on Friday, down roughly 5% over the week and more than 12% since the start of the year. Rating agency Fitch has characterized the situation as a period of elevated regulatory uncertainty, noting that the parliamentary process will be protracted and clear guidelines remain elusive.

Analysts are divided on the implications. Goldman Sachs sees the stricter requirements as a meaningful competitive handicap that could force UBS to retreat from certain international investment banking activities. The Zürcher Kantonalbank, by contrast, views the impact as manageable. The Swiss Bankers Association has thrown its weight behind UBS, arguing that the proposed subsidiary funding rules weaken the financial center and push up borrowing costs.

Should investors sell immediately? Or is it worth buying UBS?

Yet some observers also see potential upsides. An extended transition period could allow the bank to build higher capital ratios organically through retained earnings, strengthening creditor protection. The reforms may also accelerate the repatriation of capital from foreign subsidiaries back to Switzerland.

Key Dates on the Horizon

The final decision now rests with parliament, where a fierce debate is expected from the summer onward. Before that, the Economic Affairs Committee of the Council of States will take up the reform proposals on May 4, with some committee members already positioning themselves against the Federal Council’s hardline approach.

More immediate clarity could come next week. UBS is scheduled to report first-quarter results on April 29, and management has pledged to provide detailed commentary on the regulatory outlook alongside the numbers. The report will also offer concrete data on earnings momentum and the bank’s capacity to generate capital internally — critical information for investors trying to gauge whether the lender can maintain its planned $3 billion share buyback program for the current year while navigating the new requirements.

For now, UBS is sticking to its operational targets, including a return on equity of around 15% by the end of 2026. But with the earliest implementation date set for 2027, the bank faces a delicate balancing act between delivering near-term shareholder returns and preparing for a regulatory regime that could fundamentally reshape its global footprint.